Microparticles as Potential Biomarkers of Cardiovascular Disease

• Autor(a) principal: França,Carolina Nunes
• Data de Publicação: 2015
• Outros Autores: Izar,Maria Cristina de Oliveira, Amaral,Jônatas Bussador do, Tegani,Daniela Melo, Fonseca,Francisco Antonio Helfenstein
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Arquivos Brasileiros de Cardiologia (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015000200011
• topic: Cardiovascular Diseasesv; Biomarkers, Pharmacological / analysis; Cell-Derived Microparticles; Atherosclerosis / prevention & control

Primary prevention of cardiovascular disease is a choice of great relevance because of its impact on health. Some biomarkers, such as microparticles derived from different cell populations, have been considered useful in the assessment of cardiovascular disease. Microparticles are released by the membrane structures of different cell types upon activation or apoptosis, and are present in the plasma of healthy individuals (in levels considered physiological) and in patients with different pathologies. Many studies have suggested an association between microparticles and different pathological conditions, mainly the relationship with the development of cardiovascular diseases. Moreover, the effects of different lipid-lowering therapies have been described in regard to measurement of microparticles. The studies are still controversial regarding the levels of microparticles that can be considered pathological. In addition, the methodologies used still vary, suggesting the need for standardization of the different protocols applied, aiming at using microparticles as biomarkers in clinical practice.